Core Insights - Vireo Growth Inc. reported a significant increase in Q2 GAAP revenue, reaching $48.1 million, a 91% year-over-year growth, primarily driven by completed merger transactions [1][2] - The company's pro forma financial results aligned with management's expectations, with pro forma revenue and adjusted EBITDA estimated at $90.7 million and $23.2 million, respectively [3][6] - A recent refinancing of $153 million has positioned the company with a competitive cost of capital and over $100 million in cash, enhancing its financial stability [1][7] Financial Performance - Q2 GAAP revenue was $48.1 million, up from $25.1 million in Q2 2024, marking a 91.4% increase [2] - GAAP gross profit for Q2 was $20.4 million, a 50% increase from $13.6 million in the same quarter last year [2] - The gross profit margin decreased to 42.5% from 54.0% year-over-year [2] - Adjusted gross profit was $24.8 million, reflecting an 82.4% increase compared to $13.6 million in Q2 2024 [2] - SG&A expenses rose to $12.2 million, a 61.5% increase from $7.6 million in Q2 2024 [2] Mergers and Acquisitions - The company successfully closed three merger transactions during Q2, acquiring WholesomeCo in Utah, Proper Brands in Missouri, and Deep Roots Harvest in Nevada, which expanded its operational footprint to six states [4][5] - These acquisitions have positioned Vireo as one of the largest multi-state cannabis operators in the U.S. [5] Balance Sheet and Liquidity - As of June 30, 2025, total current assets were $186.2 million, including cash of $106.2 million, while total current liabilities were $51.8 million [8] - The company had a total of 1,058,617,377 shares outstanding at a share price of $0.52 [8] Future Outlook - Management expressed confidence in the company's growth trajectory following the merger transactions and refinancing, indicating a strong position for future acquisitions and industry leadership [3][6]

NEW YORK and TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the second quarter ended June 30, 2025. The Company’s Quarterly Report on Form 10-Q (the “Quarterly Report”), which includes its unaudited interim condensed consolidated financial statements for the three and six months ended June 30 ...

Core Viewpoint - Cannabis stocks and ETFs experienced significant gains following reports that U.S. President Donald Trump is considering reclassifying marijuana to a less restrictive category, which could have major implications for the industry [1][2]. Industry Impact - The potential reclassification would move marijuana from Schedule I to Schedule III, allowing cannabis companies to claim standard business tax deductions and credits, expand access to banking, and facilitate more medical research [2][6]. - A Schedule III classification could ease banking restrictions, providing businesses with better access to banking services and attracting more investors [6]. - The reclassification could shift public perception, further legitimizing the medical cannabis industry and paving the way for broader acceptance and use of marijuana as a therapeutic agent [6][7]. - Nearly 40 states in the U.S. have already legalized marijuana in various capacities, and a federal shift could encourage more states to consider legalization [7]. Market Reaction - Following the news, cannabis stocks saw substantial increases: Trulieve Cannabis Corp. surged 35%, Tilray jumped 32%, Curaleaf Holdings climbed 29%, and Canopy Growth gained 24% [3]. - In the ETF market, Roundhill Cannabis ETF rose 29.4%, Amplify Seymour Cannabis ETF increased by 27.8%, and Amplify Alternative Harvest ETF gained 27.0% [4]. ETF Details - **Roundhill Cannabis ETF (WEED)**: Concentrated exposure to leading U.S. cannabis companies, with an asset base of $6.4 million and an average daily trading volume of 42,000 shares [9]. - **Amplify Seymour Cannabis ETF (CNBS)**: Actively managed fund with diversified U.S. exposure, holding 32 securities and an asset base of $76.2 million, trading an average of 11,000 shares daily [10]. - **Amplify Alternative Harvest ETF (MJ)**: First ETF focusing on the global cannabis industry, with an asset base of $128.5 million and an average daily volume of 54,000 shares [12]. - **AdvisorShares Pure US Cannabis ETF (MSOS)**: Actively managed ETF focusing on U.S. companies, with an asset base of $521 million and an average daily volume of $9.4 million shares [13]. - **AdvisorShares Pure Cannabis ETF (YOLO)**: Actively managed fund with a focus on both domestic and foreign cannabis equity securities, holding 22 stocks with an asset base of $31.3 million and an average daily volume of 55,000 shares [14].

Group 1 - cbdMD, Inc. will host a conference call on August 14, 2025, at 4:20 p.m. Eastern Time to discuss its financial results for the third quarter of fiscal year 2025, ending June 30, 2025 [2][3] - The company is recognized as one of the leading and most trusted CBD brands in the United States, offering a comprehensive line of THC-free CBD products and Delta 9 products compliant with the Farm Act [2][3] - cbdMD's product range includes Paw CBD for pets, ATRx functional mushroom products, and Herbal Oasis, a THC-infused social seltzer designed for wellness and connection [2][3] Group 2 - The conference call can be accessed via specific dial-in numbers for USA/Canada and international participants, with a replay available for a limited time [3] - The company emphasizes its commitment to producing high-quality, U.S.-grown, THC-free CBD products, which are formulated using validated scientific methods [4]

Trulieve Cannabis (TCNN.F) FY Conference Summary Industry Overview - The conference focused on the U.S. cannabis industry, highlighting the regulatory landscape and potential changes in marijuana classification [1][2] - Trulieve Cannabis is identified as a U.S. multistate operator in the cannabis space [1] Key Points on Regulatory Reform - The Trump administration is considering rescheduling marijuana, which has generated excitement among investors [3][10] - Currently classified as a Schedule I drug, marijuana is recognized as having no accepted medical use and a high risk of abuse, similar to heroin [5][6] - In August 2023, the HHS recommended reclassifying marijuana to Schedule III, acknowledging its medical value [7] - The rescheduling process involves public comments, with 43,000 submissions favoring the change [8] - The new DEA administrator and the retirement of the administrative law judge have influenced the rescheduling process [9] - Rescheduling would not legalize marijuana but would facilitate research and reduce tax burdens on cannabis companies [11][12] - The industry faces challenges such as limited access to capital and difficulties for employees in obtaining loans and mortgages [14][15] Florida Adult Use Market - Trulieve is actively involved in the Smart and Safe Florida campaign for adult use legalization in the 2026 election [20][23] - Changes in campaign strategy include protecting children from targeted advertising, banning public smoking, and allowing additional operator licenses [24][25] - The campaign has gathered over 660,000 signatures, with a deadline of February 2026 for the required 880,000 [28] - The Florida Supreme Court will review the ballot language by April 1, 2026 [30] Product Strategy and Consumer Trends - Trulieve focuses on customer experience, achieving high Net Promoter Scores (NPS) [31] - There has been a shift in consumer preference towards value-tier products due to inflationary pressures [33] - The company has adapted its promotional strategies to offer more approachable pricing and bundle deals [34] - The introduction of hemp-derived THC beverages has opened new market opportunities, reaching consumers who may not seek medical cannabis [40][41] - The Onward and Upward beverage lines are designed to provide social alternatives without hangovers [42][43] Capital Allocation and Financial Strategy - Trulieve has $368 million in private placement notes due in October 2026, with plans to refinance part of this debt [46][48] - The company is investing in the Smart and Safe Florida campaign and focusing on organic growth and potential acquisitions [49] - Capital expenditures for the year are projected at $40 million, primarily for store openings and remodels [49] - The board regularly discusses share buybacks, but the focus has been on reinvesting in the business [51]

Core Viewpoint - LEEF Brands, Inc. is increasing its private placement offering to issue up to 7,600,000 units at a price of C$0.25 per unit, aiming for gross proceeds of up to C$1.9 million [1][5]. Group 1: Offering Details - Each unit will consist of one common share and one common share purchase warrant, with each warrant allowing the purchase of an additional common share at C$0.30 for 24 months [2]. - The offering is conducted under the listed issuer financing exemption, meaning the securities issued will not be subject to a statutory hold period under Canadian securities laws [3]. Group 2: Use of Proceeds - The net proceeds from the offering are expected to be used for general working capital, supporting operations from the successful harvest at Salisbury Canyon Ranch, and accelerating operations in New York [4]. Group 3: Management Commentary - The CEO of LEEF Brands stated that the increased financing reflects investor confidence and positions the company for expansion in extraction operations, enhancing vertical integration and exploring new revenue streams [5]. Group 4: Company Overview - LEEF Brands Inc. is a leading extraction and manufacturing cannabis company based in California and New York, with a comprehensive supply chain and innovative manufacturing processes [6].

Core Insights - Aurora Cannabis Inc. is launching its Whistler Cannabis Co. brand in Australia, expanding its global footprint and offering Australian patients access to premium Canadian cannabis products [1][2][3] - The company emphasizes its commitment to quality and patient care, leveraging its Canadian cultivation expertise to ensure consistent product quality [2][3] Product Launch Details - The first two products from Whistler Cannabis Co. to be introduced in Australia are Ginger Breath and Critical Diesel, both featuring high THC content [7] - Ginger Breath has a THC level of 32% and is an Indica strain, while Critical Diesel has a THC level of 28% and is a Sativa strain [7] Company Background - Aurora Cannabis Inc. is a leading global medical cannabis company headquartered in Edmonton, Alberta, with a diverse portfolio of brands serving both medical and consumer markets across multiple regions [4][5] - The company is recognized for its robust regulatory expertise and commitment to science and innovation, which supports its success in international markets [3][4]

Market Expansion - Cannabis-infused drinks on draft are now available in 3 states [1]

Group 1 - Cronos Group Inc. (NASDAQ: CRON) stock price increased by 15% on news that President Trump’s administration will consider rescheduling cannabis in the coming weeks [1] - The announcement has implications for Canadian cannabis licensed producers (LPs) and U.S. cannabis Multi-State Operators [1] Group 2 - The article is part of a monthly report on the cannabis industry, highlighting the author's expertise in technical stock analysis, option strategies, small cap strategies, and emerging markets [1]

Brandon Gomez, tell us more about cannabis stocks today. Hey, Scott. Yeah, look, it was a massive surge in cannabis names.We've been here before, though. Trump once again voicing his support to reclassify cannabis as a less dangerous drug. Now, this would align it with steroids or Tylenol with codine rather than more dangerous drugs like heroin LSD.Now, it could blaze a new trail for the industry, but investors shouldn't light up with celebration just yet. Despite Trump saying today that a decision could co ...